Previous studies have implicated ERs in prostatic disease, with ERα associated with LUTS in humans and mice, while ERβ may limit prostatic hyperplasia through enhanced epithelial cell apoptosis [15, 16]. Here, ESR2 is linked to benign prostatic hyperplasia.